TECVAYLI 153mg/1.7ml (Teclistamab-cqyv Vials) 153mg/1.7ml (90mg/ml)

TECVAYLI 153mg/1.7ml (90mg/ml) is a prescription medication in vial form used for targeted therapy. Store between 2-8°C to maintain potency. Always follow healthcare provider instructions for safe use. Primary keyword: teclistamab injection.

Strength

153mg/1.7ml (90mg/ml)

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Janssen Cilag Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Teclistamab-cqyv is a bispecific antibody therapy designed for targeted treatment in certain cancers. It works by helping the immune system recognize and attack cancer cells. This medication is typically used when other treatments have not been effective. Patients often ask, what is teclistamab used for in cancer care.

Side Effects

As a targeted therapy, teclistamab may cause immune-related responses as the body adjusts to treatment. Common effects include fatigue, injection site reactions, or mild flu-like symptoms. These responses vary by individual and are typically monitored by healthcare providers.

Precautions & Warnings

TECVAYLI requires careful handling and storage at 2-8°C to preserve efficacy. Always check the vial for particles or discoloration before use. Keep out of reach of children and pets. Dispose of used vials and supplies according to local medical waste guidelines.

Avoid Interactions

Avoid alcohol and other medications that may suppress the immune system while using teclistamab. Certain vaccines or live therapies may interact with its effects. Always inform your healthcare provider about all medications, supplements, or herbal products you are taking before starting treatment.

Frequently Asked Questions

Teclistamab-cqyv is used in targeted therapy for certain cancers, particularly when other treatments are no longer effective.

Store between 2-8°C and protect from light. Do not freeze or shake the vial.

Teclistamab is a prescription medication and should only be obtained through licensed healthcare providers or pharmacies.

Common effects may include fatigue, injection site reactions, or mild flu-like symptoms. Always consult your doctor for personalized advice.

No, TECVAYLI is a targeted therapy using bispecific antibodies, not traditional chemotherapy.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.